PDF(Sci-hub)
Abstract：
OnPAR-the Online Partnership to Accelerate Research-seeks to provide a second opportunity for funding of high-quality, unfunded applications originally submitted to the National Institutes of Health and other national and international funding agencies. OnPAR will match applicable, unfunded applications with the research priorities of nongovernment organizations such as private biomedical foundations, pharmaceutical companies, venture capital funds, and other private funds. Funding organization members will review and make final funding decisions through a simple, 2-step process whereby applicants can submit public abstracts directly to OnPAR. If a member requests additional information, then, by invitation only, an applicant can submit their original unfunded application and their peer review summary statement. Advancing research discovery and drug development to improve clinical outcomes for patients afflicted with or at risk for disease is the primary goal of OnPAR. OnPAR invites the scientific community to fully participate in this new funding paradigm by submitting their National Institutes of Health public abstracts so that funding members can review and potentially support these high-quality, unfunded applications.
摘要：
OnPAR-加速研究的在线合作伙伴关系-旨在为高质量的资金提供第二次机会，最初提交给美国国立卫生研究院和其他国家和国际资助机构的无资金申请。OnPAR将匹配适用,与非政府组织如私人生物医学基金会的研究重点无资金的应用程序，制药公司,风险投资基金,其他私人基金。资助组织成员将通过一个简单的、2步程序，申请人可以直接向OnPAR提交公开摘要。如果成员请求其他信息，然后,仅通过邀请，申请人可以提交其原始无资金支持的申请和同行评审摘要声明。推进研究发现和药物开发以改善患有疾病或有疾病风险的患者的临床结果是OnPAR的主要目标。OnPAR邀请科学界通过提交其国立卫生研究院公共摘要来充分参与这一新的资助范式，以便资助成员可以审查并可能支持这些高质量的研究，无资金的申请。
